| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d19cfdd159e440f1e033a5a3bc3e5e1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate |
2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec06c0a816470b7ba4455abe64c1d6a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28105b214557395e992ff4d9466c34c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1374c1c2f06c9e533dc41a07204d8d1c |
| publicationDate |
2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013151719-A2 |
| titleOfInvention |
Fluorinated oxazolidinone derivatives |
| abstract |
The invention relates to fluorinated compounds and their use in the field of blood coagulation. Novel fluorinated oxazolidinone derivatives of rivaroxaban and pharmaceutically acceptable salts or solvates thereof and their use as medicinally active compounds for the treatment and prevention of disorders are described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11154558-B2 |
| priorityDate |
2012-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |